Standard Biotools (LAB) Gross Profit Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.11% |
| Dec 31, 2025 | -22.93% |
| Sep 30, 2025 | -14.53% |
| Jun 30, 2025 | -2.11% |
| Mar 31, 2025 | -3.20% |
| Dec 31, 2024 | -8.69% |
| Sep 30, 2024 | -2.61% |
| Jun 30, 2024 | -7.55% |
| Mar 31, 2024 | 7.32% |
| Dec 31, 2023 | -6.62% |
| Sep 30, 2023 | -6.75% |
| Jun 30, 2023 | 0.02% |
| Mar 31, 2023 | -1.77% |
| Dec 31, 2022 | 21.01% |
| Sep 30, 2022 | -7.11% |
| Jun 30, 2022 | -27.91% |
| Mar 31, 2022 | 0.13% |
| Sep 30, 2021 | -6.26% |
| Jun 30, 2021 | -7.44% |
| Mar 31, 2021 | 11.01% |
| Dec 31, 2020 | -6.51% |
| Sep 30, 2020 | -5.55% |
| Jun 30, 2020 | -15.72% |
| Mar 31, 2020 | -5.04% |
| Dec 31, 2019 | -11.24% |
| Sep 30, 2019 | -13.62% |
| Jun 30, 2019 | -2.74% |
| Mar 31, 2019 | -0.04% |
| Dec 31, 2018 | -10.89% |
| Sep 30, 2018 | 3.77% |
| Jun 30, 2018 | 1.51% |
| Mar 31, 2018 | 5.50% |
| Dec 31, 2017 | -29.61% |
| Sep 30, 2017 | 7.55% |
| Jun 30, 2017 | 20.31% |
| Mar 31, 2017 | 26.97% |
| Dec 31, 2016 | 2.51% |
| Sep 30, 2016 | 23.52% |
| Jun 30, 2016 | 28.74% |
| Mar 31, 2016 | 25.79% |
| Dec 31, 2015 | 57.76% |
| Sep 30, 2015 | 73.19% |
| Jun 30, 2015 | 40.26% |